MODERNA INC CEDEAR EACH 19 REP 1 ORDMODERNA INC CEDEAR EACH 19 REP 1 ORDMODERNA INC CEDEAR EACH 19 REP 1 ORD

MODERNA INC CEDEAR EACH 19 REP 1 ORD

No trades
See on Supercharts

MRNA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MRNA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company